Loading...
IMMU-16. PROGRAMMED DEATH LIGAND 1 EXPRESSION AND TUMOR INFILTRATING LYMPHOCYTES IN TUMORS ASSOCIATED WITH NEUROFIBROMATOSIS TYPE 1 AND 2
BACKGROUND: Immune checkpoint inhibitors targeting programmed cell death 1 (PD-1) or its ligand (PD-L1) have been shown to be effective in treating subsets of patients with a variety of cancers. Biomarker studies have found positive associations between clinical response rates and PD-L1 expression o...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475099/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.126 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|